Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Moss

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Life Sciences|March 27, 2004
Methylnaltrexone prevents morphine-induced kaolin intake in the ratHan H Aung, Sangeeta R Mehendale, Jing-Tian Xie, et al.
Anesthesiology|February 21, 2012
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasisFrances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Clinical Pharmacology and Therapeutics|January 16, 2024
Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing RegimenPeter N Morcos, Jonathan Moss, Josh Veasy, et al.
BMJ Open|July 12, 2019
Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative studyCaoimhe Ryan, Hannah Hesselgreaves, Olivia Wu, et al.
Mayo Clinic Proceedings|March 6, 2012
Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patientsSergio B Sawh, Ibrahim P Selvaraj, Akila Danga, et al.
Circulation. Cardiovascular Interventions|August 15, 2024
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL TrialHannah O'Keeffe, Darren Green, Aine de Bhailis, et al.
American Journal of Respiratory Cell and Molecular Biology|March 31, 2007
Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivationPatrick A Singleton, Liliana Moreno-Vinasco, Saad Sammani, et al.
Plos One|March 26, 2014
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancerFrances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Health Technology Assessment (Winchester, England)|January 21, 2016
The relationship between pelvic vein incompetence and chronic pelvic pain in women: systematic reviews of diagnosis and treatment effectivenessRita Champaneria, Laila Shah, Jonathan Moss, et al.
Brain Communications|September 25, 2025
Multiregional blood-brain barrier phenotyping identifies the prefrontal cortex as the most vulnerable region to ageing in miceIsabel Bravo-Ferrer, Katrine Gaasdal-Bech, Chiara Colvin, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Life Sciences|March 27, 2004
Methylnaltrexone prevents morphine-induced kaolin intake in the ratHan H Aung, Sangeeta R Mehendale, Jing-Tian Xie, et al.
Anesthesiology|February 21, 2012
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasisFrances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Clinical Pharmacology and Therapeutics|January 16, 2024
Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing RegimenPeter N Morcos, Jonathan Moss, Josh Veasy, et al.
BMJ Open|July 12, 2019
Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative studyCaoimhe Ryan, Hannah Hesselgreaves, Olivia Wu, et al.
Mayo Clinic Proceedings|March 6, 2012
Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patientsSergio B Sawh, Ibrahim P Selvaraj, Akila Danga, et al.
Circulation. Cardiovascular Interventions|August 15, 2024
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL TrialHannah O'Keeffe, Darren Green, Aine de Bhailis, et al.
American Journal of Respiratory Cell and Molecular Biology|March 31, 2007
Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivationPatrick A Singleton, Liliana Moreno-Vinasco, Saad Sammani, et al.
Plos One|March 26, 2014
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancerFrances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Health Technology Assessment (Winchester, England)|January 21, 2016
The relationship between pelvic vein incompetence and chronic pelvic pain in women: systematic reviews of diagnosis and treatment effectivenessRita Champaneria, Laila Shah, Jonathan Moss, et al.
Brain Communications|September 25, 2025
Multiregional blood-brain barrier phenotyping identifies the prefrontal cortex as the most vulnerable region to ageing in miceIsabel Bravo-Ferrer, Katrine Gaasdal-Bech, Chiara Colvin, et al.
Pageof 7